The challenge infection induced BVDV Erns- and BVDV NS3-specific antibodies in the controls and in the vaccinated groups, confirming the applicability of the double marker vaccine strategy to discriminate vaccinated from BVDV-1-infected animals. The gene discussed is KRAS; the disease is infection.